fulvestrant has been researched along with megestrol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Catherino, WH; Jordan, VC | 1 |
DeMichele, A; Gogineni, K | 1 |
2 review(s) available for fulvestrant and megestrol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current approaches to the management of Her2-negative metastatic breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Deoxycytidine; Doxorubicin; Estradiol; Female; Fulvestrant; Gemcitabine; Humans; Megestrol; Ovary; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; TOR Serine-Threonine Kinases | 2012 |
1 other study(ies) available for fulvestrant and megestrol
Article | Year |
---|---|
Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity.
Topics: Animals; Base Sequence; Binding Sites; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Estradiol Congeners; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Luciferases; Megestrol; Molecular Sequence Data; Norpregnadienes; Oligodeoxyribonucleotides; Progesterone Congeners; Recombinant Proteins; Structure-Activity Relationship; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vitellogenins; Xenopus | 1995 |